IsoRay

IsoRay Net Income

Delisted

The Net Income of IsoRay (ISR) as of Nov 4, 2026 is -7.15 M USD. In the previous year, Net Income was -3.20 M USD — a change of 123.74% (lower).

Net Income

-7.15 MUSD

YoY

123.74%

Last updated:

In 2022, IsoRay's profit amounted to -7.15 M USD, a 123.74% increase from the -3.20 M USD profit recorded in the previous year.

The IsoRay Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2019
-4.85 M USD
Jan 1, 2020
-3.27 M USD
Jan 1, 2021
-3.20 M USD
Jan 1, 2022
-7.15 M USD
Jan 1, 2023 (e)
-7.11 M USD
Jan 1, 2024 (e)
0.00 USD
Jan 1, 2025 (e)
5.19 M USD
Jan 1, 2026 (e)
4.75 M USD
The IsoRay Net Income history
YEARNet IncomeYoY
est4.75 MUSD-8.64%
est5.19 MUSD—
est0.00USD-100.00%
est-7.11 MUSD-0.66%
-7.15 MUSD+123.74%
-3.20 MUSD-2.20%
-3.27 MUSD-32.60%
-4.85 MUSD-27.61%
-6.70 MUSD+8.73%
-6.16 MUSD+30.81%
-4.71 MUSD+27.97%
-3.68 MUSD-38.23%
-5.96 MUSD+54.52%
-3.86 MUSD+10.54%
-3.49 MUSD+22.75%
-2.84 MUSD-29.54%
-4.03 MUSD-34.52%
-6.16 MUSD-28.01%
-8.56 MUSD-10.91%
-9.61 MUSD+16.88%
-8.22 MUSD+27,293.77%
-30,000.00USD-139.60%
75,757.00USD-226.20%
-60,027.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IsoRay Revenue

IsoRay Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
7.31 M USD
-5.28 M USD
-4.85 M USD
Jan 1, 2020
9.68 M USD
-3.48 M USD
-3.27 M USD
Jan 1, 2021
10.05 M USD
-3.44 M USD
-3.20 M USD
Jan 1, 2022
10.80 M USD
-7.39 M USD
-7.15 M USD
Jan 1, 2023 (e)
16.00 M USD
-7.37 M USD
-7.11 M USD
Jan 1, 2024 (e)
23.96 M USD
6.36 M USD
0.00 USD
Jan 1, 2025 (e)
32.62 M USD
6.14 M USD
5.19 M USD
Jan 1, 2026 (e)
38.51 M USD
5.99 M USD
4.75 M USD

IsoRay Margins

IsoRay stock margins

The IsoRay margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IsoRay. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IsoRay.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
41.66 %
-72.16 %
-66.31 %
Jan 1, 2020
52.93 %
-35.91 %
-33.77 %
Jan 1, 2021
50.94 %
-34.19 %
-31.80 %
Jan 1, 2022
42.76 %
-68.47 %
-66.26 %
Jan 1, 2023 (e)
42.76 %
-46.09 %
-44.41 %
Jan 1, 2024 (e)
42.76 %
26.55 %
0.00 %
Jan 1, 2025 (e)
42.76 %
18.83 %
15.92 %
Jan 1, 2026 (e)
42.76 %
15.56 %
12.32 %

IsoRay Stock analysis

What does IsoRay do? The company IsoRay Inc is a leading global company in the field of brachytherapy and specializes in the development of novel medical devices for the treatment of cancer. The company's history dates back to the 1980s when it was founded by a team of doctors and scientists. IsoRay Inc's business model is based on the research, development, and manufacturing of medical products used in the treatment of cancer. Brachytherapy is a particularly important focus. This involves a treatment method where radioactive seeds or sources are directly implanted into the tumor. The radiation destroys the cancer cells without damaging the surrounding tissue. IsoRay Inc's product range includes a variety of medical devices and accessories for conducting brachytherapy procedures. The company specializes in the development of high-tech products that enable precise and effective radiation therapy. This includes, for example, radioactive seeds that are directly implanted into the tumor or apparatuses that can selectively use radiation in specific structures of the body. A special focus of IsoRay Inc is computer-assisted planning of brachytherapy treatments. The tumor is precisely measured and the radiation sources are individually customized based on the data to achieve an optimal radiation dose. This planning is done using modern software and is an important factor for the successful treatment of cancer. In addition to research and development of medical products, IsoRay Inc also encompasses the production and distribution of these products. The company operates in more than 30 countries worldwide and collaborates closely with numerous clinics and practices to research and improve new technologies in the field of radiation therapy. One of IsoRay Inc's most well-known products is the "Cesium-131 Brachytherapy seed." This radioactive seed is particularly small and therefore ideal for targeted radiation therapy of tumors. It is used in almost all clinical areas worldwide and is considered particularly safe and effective. Other products of the company include the "Gladius™ Applicator Needle," a device for precise placement of radiation sources in tumors, as well as "Intraoperative Application Systems" that enable effective radiation therapy during surgery. Overall, IsoRay Inc is considered an innovative and successful company in the field of brachytherapy and radiation therapy. The constant development and improvement of its own products is a key factor for the company's success. High quality and close collaboration with research and practice are central to its operations. IsoRay is one of the most popular companies on Eulerpool.

Net Income Details

Understanding IsoRay's Profit Margins

The profit margins of IsoRay represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of IsoRay's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating IsoRay's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

IsoRay's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When IsoRay’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about IsoRay stock

Net Income of IsoRay is -7.15 M USD in 2022.

Net Income of IsoRay changed from -3.20 M USD to -7.15 M USD, representing a 123.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Income IsoRay since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's IsoRay historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — IsoRay

All Key Metrics — IsoRay